Prior studies identified a segment of the CD2 cytoplasmic domain between amino acid (aa) residues 253 and 287 as important in T lymphocyte signal transduction . This region contains two repeats of the sequence motif PPPGHR, thought to form a "cage" structure involved in CD2-mediated signaling. To evaluate this segment, a series of mutant human CD2 molecules were produced by oligonucleotide-directed mutagenesis and inserted into the ovalbumin-specific, I-Ad-restricted murine T-T hybridoma 3DO54.8 using the DOL retroviral system . CD2 M1 (271-272), CD2 M2 (278-279), and CD2 M4 (264-265) mutants replaced the positively charged adjacent as histidine and arginine (HR) in the wild-type CD2 sequence with aspartic and glutamic acid (DE) at positions 271-272, 278-279, and 264-265, respectively. In addition, a truncation mutant, CD2 M3 (268), containing only 57 ofthe 117 cytoplasmic as and terminating before the second PPPGHR sequence, was generated . Stimulation oftransfectants CD2 FL, CD2 MI (271-272), and CD2 M2 (278-279) with anti-T112 + anti-T113 antibodies resulted in a rise in cytosolic-free calcium ([Ca2+]i) and subsequent interleukin 2 (IL2) secretion . In contrast, CD2 M4 (264-265) transfectants could not be activated in either assay. Thus, alteration of histidine 264 and/or arginine 265 within the first PPPGHR motif affects the process of signal transduction via CD2, whereas identical mutations in residues at 271-272 or 278-279 were individually without effect . Consistent with these data, CD2 M3 (268) transfectants were able to generate a detectable amount of IL2 via CD2 triggering. These data support the notion that the PPPGHR motif at as 260-265 is important for activation of T lymphocytes via the CD2 molecule.
T he CD2 (T11) molecule is a 50-55-kD transmembrane glycoprotein expressed on a vast majority of thymocytes and virtually all peripheral T lymphocytes (reviewed in reference 1). Functional characterization of the human molecule has clearly established that CD2 serves a dual role in mediating T cell adhesion and activation (2-6) . Based on microchemical analysis of human CD2, as well as cDNA and/or genomic cloning of mouse, rat, and human molecules, the structure of the CD2 molecule has been well defined (reviewed in reference 1). Human CD2 consists of a 185-amino acid (aa) extracellular domain, a 25-aa transmembrane segment, and a 117-aa cytoplasmic domain rich in prolines and basic residues. By analysis ofmurine T cell transfectants expressing the human wild-type CD2 cDNA as well as deletion mutants, we and others have previously established that the CD2 cytoplasmic region is necessary for activation via CD2 (7-9). More importantly, we were able to identify a segment of the cytoplasmic domain between as 253 and 287 necessary for CD2-mediated activation (7) . This region contains four histidines at as positions 264, 271, 278, and 282 , and includes two tandemly repeated segments (PPPGHR, (260) (261) (262) (263) (264) (265) . A highly homologous region is found in murine CD2 in a corresponding position as well. To further evaluate the role of this segment for activation via CD2, a series of substitution mutants of human CD2 have been generated by oligonucleotide-directed mutagenesis and expressed in the 3DO54.8 murine T cell line for functional characterization .
Materials and Methods

Construction of Truncated and Mutated Human CD2 Molecules and
Tmnsfection into a Murine T Cell Hybridoma. Constructs were generated by oligonucleotide-directed in vitro mutagenesis, as previously described (7) . The full-length human CD2 cDNA, PB2 insert (10), was subdoned into the BamHI site of M13mp18 . The synthetic oligonucleotides used for mutation are 5'-CAGGCACCTAGTG-ATGAGCCCCCGCCTCCT3' for CD2 M1 (271-272), which changes the wild-type sequence CATCGT (His-Arg) into GATGAG (Asp-Glu) at as 271-272 ; 5'-000TCCTGGAGATGAGGTTCA-GCACCAG-3' for CD2 M2 (278-279), which changes the wildtype sequence CACCGT (His-Arg) into GATGAG (Asp-Glu) at as 278-279) ; 5'-CATCGTTCCCAGTAACCTAGTCATCGT 3' for CD2 M3 (268), which changes the wild-type sequence GCA (Ala) into TAA, a stop codon resulting in a CD2 molecule truncated at as position 268 ; and 5'-CCACCACCTGGTGATGAGT000-AGGCACCT3' for CD2 M4 (264-265) , which changes the wildtype sequence CATCGT (His-Arg) into GATGAG (Asp-Glu) at as 264-265 . The mutant DNAs were subcloned into the retroviral expression vector DOL and transfected by Cat + precipitation into 02 cell to generate the individual virus stock, as described in detail previously (7) . Each virus was then used to infect the murine T cell hybridoma 3DO54 .8 . The G418-resistant clones were further selected by indirect immunofluorescence for surface CD2 expression and maintained as described (7) . A single colony arising from one well in selection media was considered clonal .
Sequence Analysis ofHuman CD2 cDNAs in the Mutant. DNA fragments corresponding to by 739-1117 ofthe human CD2 cDNA (10) were generated by amplifying single-stranded cDNA generated with the 3' primer of CD2 and reverse transcriptase (Life Sciences, St. Petersburg, FL) from the total cytosolic RNA ofeach T cell clone by PCR with CD2-specific primers (11) . The conditions used to perform PCR were as follows : denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 1 min, for a total of 40 cycles of amplification . The 5' primer 5'-AGGATCCAACAGAGGAGTCGGAGAAAT3'corresponds to by 739-758 of CD2 cDNA and contains a BamHI restriction enzyme recognition sequence . The 3' primer 5'-GGGATCCACA-GTGCTTTTTATTGAA-3' corresponds to by 1100-1117 of CD2 cDNA and includes a BamHI recognition sequence . The fragments generated were subdoned into the BamHI site of pGEM-4 blue (Promega Biotec, Madison, WI) and subjected to double-stranded DNA sequencing to confirm the presence of the correct mutation for each clone .
Measurement of Cytosolic Ca' and 11,2 Production. Measurement of cytosolic Cat* concentrations was determined according to a previously described method (7) . For quantification of 11,2 production, 105 cells/well were incubated in 96-well roundbottomed plates for 24 h in the presence of either OVA (1 mg/ml final concentration) plus 105 A20-11 B lymphoma cells or anti-T112 + anti-T113 (ascites 1 :200) or culture medium . A 5-ng/ml final concentration of PMA was added to all experimental samples including media control . Subsequently, supernatants were harvested and titrated in triplicate for their ability to support the growth of 10,000 CTL1r20 cells by [3H]thymidine incorporation, as previously described (7), in parallel to known concentrations of rIL2 (Biogen, Cambridge, MA) .
Results and Discussion
A series of mutants was generated within the cytoplasmic region of human CD2 including the two tandem repeats of the sequence PPPGHR (Fig. 1) . In three mutants, two negatively charged as residues (D and E) were substituted for adjacent positively charged H and R residues in the CD2 sequence at as positions 264-265, 271-272, or 278-279 . In another mutation, a termination codon was introduced at as 268, thereby resulting in the loss of the second PPPGHR repeat as well as the other COOH-terminal components of the CD2 cytoplasmic tail . These four modified cDNAs were individually transfected into the 3DO54.8 cell line, a murine T cell hybridoma specific for OVA in the context of the H-2 molecule (I-Ad), using a previously described retroviral system (7) .
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PPPGHR Motif in CD2 Clones expressing each of these forms of CD2 were obtained and compared with CD2FL clone 1, a clone derived from 3DO54 .8 transfected with wild-type human CD2 expressing a similar level of surface CD2 (7) . Nomenclature of clones used in the subsequent functional analyses is as follows : CD2 M1 (271-272) clones express CD2 cDNA with a DE for HR substitution at as positions 271-272 ; CD2 M2 (278-279) clones express the DE for HR substitution at as positions 278-279 ; CD2 M4 (264-265) clones express the DE for HR substitution at as [264] [265] and CD2 M3 (268) clones express CD2 molecules truncated after 57 cytoplasmic residues. The sequence of each mutation was confirmed by both double-stranded sequencing of the plasmid used for transfection as well as by sequencing the PCR products corresponding to nucleotides 739-1117, as amplified from cellular RNA derived from individual transfected clones.
Because perturbation of the CD2 extracellular segment with antiT112 + antiT113 antibodies induces human T cell activation and initiates a rise in intracellular-free calcium ([Cal+]i) (1, 5), we tested the CD2 mutants for their ability to alter [Ca2 +], in the transfected 3DO54.8 cell lines inwhich they were expressed . In Fig. 2 findings were confirmed with two additional M3 clones (clones 17 and 95) and two additional M4 clones (clones 36 and 122) .
Perturbation of the CD2 molecule with a combination of anti-T112 + anti-T113 mAbs was previously shown to result in 11,2 production (2) . We, therefore, next determined whether this mitogenic combination of anti-CD2 mAbs stimulated any of the CD2 mutants, and compared the level of IL2 produced with that obtained by stimulating each cell type with OVA in the context of I-Ad APC. As shown in Fig. 3 , substantial levels of 11,2 were produced by CD2 FL (clone 1), CD2 M2 (clone 38 .1), CD2 M3 (clone 176), and CD2 M4 (clone 41) upon antigenic stimulation, as assayed by the ability of supernatants from transfected cells to induce proliferation of CTLL20 . The amount of 11,2 generated from the CD2 FL clone after CD2 triggering was comparable with that after antigen stimulation . A similar result was obtained for CD2 M2 cells (Fig. 3) . As we previously reported, this was also the case for CD2 M1 (clone 232; reference 7). Although cells of the CD2 M2 clone 38.1 express higher levels of surface CD2 than CD2 FL, no defect in CD2 M2 function was observed upon triggering cells of the CD2 M2 clone 38 .4, which express levels of CD2 comparable with that on CD2 FL cells (see Fig . 3 legend) . Thus, the 11,2 induction function of the CD2 M2 molecule is not altered. In contrast, anti-CD2 stimulated no detectable IL2 production from CD2 M4 and induced significantly less 11,2 from CD2 M3 relative to stimulation by antigen and MHC . These results indicate that IL2 production from TCR stimulation of CD2 M4 and CD2 M3 clones is intact but that mutations of the CD2 molecule expressed in these clones has altered their signaling capacity. As indicated in the Fig. 3 The CD2 expression of these clones present in copy number per cell is 5,000, 30,000, 8,000, and 4,000, respectively. This experiment is representative of five independent experiments using in addition clones CD2 FL clone 2, CD2 M2 clone 38 .4, CD2 M3 clone 95, CD2 M4 clone 36, and CD2 M4 clone 122, with 4,500, 3,500, 4,000, 2,500, and 3,500 CD2 molecules expressed per cell, respectively, as evaluated by indirect immunofluorescence and FRCS analysis.
to produce IL2 upon CD2 stimulation . Furthermore, the lack of IL2 production was not a consequence of reduced CD2 expression, because the level of CD2 surface expression on the nonfunctional M4 series can be compared with the level of CD2 found on the functional M2 series (3,000-4,000 copies/cell, respectively) . Collectively, the above results show that alteration of the positively charged histidine 264 and arginine 265 residues within the first PPPGHR motif of the human CD2 cytoplasmic domain markedly affects the process of signal transduction via this molecule. In contrast, alteration of histidine and arginine residues at positions 271-272 or 278-279 were without detectable effect, implying that the effect of the nonconservative substitutions is strictly sequence position dependent . Such a finding might not have been anticipated if the histidine residues were each involved in forming a portion of a cage for an ion or small, charged regulatory molecule. While the position of residue substitutions in the mutant CD2 molecules may define the precise site(s) involved in CD2 signal transduction, we cannot exclude the possibility that the nonconservative substitutions structurally altered the CD2 cytoplasmic domain elsewhere . Furthermore, the ability of the M3 truncation to function in signaling 11,2 production, although at reduced levels relative to CD2 FL, supports the importance of the histidine and/or arginine residues in the first PPPGHR motif. These data are also consistent with our earlier observations from analysis of a panel of CD2 cytoplasmic truncation mutants (7), and extend the findings by suggesting that some component between as 268-287, aside from the histidine residues, contributes to signal transduction. A number ofimportant issues are raised by the data herein. First, what is the structural nature o£ the PPPGHR motif?
